ASSESSMENT OF THE QUALITY OF LIFE, PHYSICAL ACTIVITY, DEPRESSION AND ANXIETY OF PATIENTS UNDER ONCOLOGY CARE
Author(s)
Horváth K1, Ács P1, Boncz I1, Járomi M1, Molics B2, Hock M1
1University of Pécs, Pécs, Hungary, 2University of Pécs, Pécs, BA, Hungary
OBJECTIVES: The number of cancerous diseases is increasing year after year worldwide. Patients are getting more targeted treatment, although they still have to count with possible side effects. It is important to the patients to be in good physical and psychological condition so that they can better deal with side effects. Three groups: a. patients receiving radiotherapy; b. patients receiving chemotherapy while having in hospital ward placement; c. patients receiving ambulant chemotherapy. Our aim is to examine the quality of life, physical activity, level of depression and anxiety of these patients. METHODS: Our study took between October 2018 and December 2018. Self-filled questionnaire sampling based on personal inquiry. Data: internationally accepted validated questionnaires (Beck Depression Questionnaire, SF-36, IPAQ, STAI), a self-developed questionnaire (demographic, disease data). Microsoft Excel 2013, IBM SPSS version 22. RESULTS: 116 respondents: 56 women, 60 men took part of our study. The 3 subgroups: 41 persons (35%) radiotherapy, 44 (38%) chemotherapy in in-patient hospital care, 31 (27%) ambulant chemotherapy. Mild depression is most common in all three treatments (women: 60.7%; men: 71.7%). Most people with radiotherapy are suffering from moderate to severe depression. 64 persons doing low physical activity (55.2%), 22 medium (19%), 30 high (25.9%). Significant relationship between treatment types and quality of life scores (p<0.006), between radiotherapy participants and ambulant chemotherapy participants (p=0.008), marginal significant difference between radiotherapy and class chemotherapy (p=0.077). A marginal relationship between the level of depression and the types of treatment (p=0.095), (C=0.216). Significant difference between the radiation therapy and the chemotherapy (p=0.042, p=0.022) for the depression. Only 7.8% of the patients don't suffer from mild depression. Those with ambulatory chemotherapy have the highest anxiety (50.32), but the best quality of life (53.89). CONCLUSIONS: Hospital in-patient treatment reduces the level of anxiety, but has a negative effect on quality of life.
Conference/Value in Health Info
2019-11, ISPOR Europe 2019, Copenhagen, Denmark
Code
PCN16
Topic
Health Service Delivery & Process of Care, Patient-Centered Research
Topic Subcategory
Hospital and Clinical Practices, Patient-reported Outcomes & Quality of Life Outcomes
Disease
Mental Health, Musculoskeletal Disorders, Oncology